SCHEDULE 13G
Statement of Beneficial Ownership
Perspective Therapeutics, Inc. Filed Acc 0000093751-26-000524
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| STATE STREET CORPORATION | 6,051,771 | 5.3% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-12 SCHEDULE 13D/A · Lantheus Holdings, Inc. 3.9%
- 2026-11-10 SCHEDULE 13G · STATE STREET CORPORATION 1.8%
- 2026-09-23 SCHEDULE 13D/A · Lantheus Holdings, Inc. 7.7%
- 2026-09-04 SCHEDULE 13D/A · Lantheus Holdings, Inc. 10.0%
- 2026-08-07 SCHEDULE 13G · STATE STREET CORPORATION 5.3%
- 2026-07-29 SCHEDULE 13G · BlackRock, Inc. 6.8%
- 2026-07-20 SCHEDULE 13G · Millennium Management LLC 5.3%
- 2026-04-27 SCHEDULE 13G/A · BlackRock, Inc. 4.6%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…